NCT00849836

Brief Summary

The purpose of this study is:

  • To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
  • To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

February 23, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 24, 2009

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2010

Completed
Last Updated

February 24, 2009

Status Verified

February 1, 2009

First QC Date

February 23, 2009

Last Update Submit

February 23, 2009

Conditions

Study Arms (3)

Acute exacerbation

Stable disease

Healthy control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with acute exacerbation of asthma or COPD, patients with stable status of those disease, and the healthy control subjects

You may qualify if:

  • \> 18 years olds
  • Both sexes
  • Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
  • Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
  • For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chonbuk National University Medical School

Jeonju, 561-180, South Korea

RECRUITING

MeSH Terms

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

So Ri Kim, MD, PhD

CONTACT

Yong Chul Lee, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 23, 2009

First Posted

February 24, 2009

Study Start

February 1, 2009

Study Completion

January 1, 2010

Last Updated

February 24, 2009

Record last verified: 2009-02

Locations